Organigram FY2024 EPS Raised by Alliance Global Partners

Organigram Holdings Inc. (NASDAQ:OGI) – Research analysts at Alliance Global Partners boosted their FY2024 earnings estimates for shares of Organigram in a report released on Monday, December 9th. Alliance Global Partners analyst A. Grey now anticipates that the company will post earnings of ($0.18) per share for the year, up from their prior estimate of ($0.19). The consensus estimate for Organigram’s current full-year earnings is ($0.21) per share. Alliance Global Partners also issued estimates for Organigram’s Q4 2024 earnings at ($0.02) EPS, Q2 2025 earnings at ($0.01) EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at ($0.01) EPS and FY2025 earnings at ($0.02) EPS.

Organigram Price Performance

Shares of Organigram stock opened at $1.51 on Wednesday. The stock has a market cap of $164.46 million, a price-to-earnings ratio of -3.60 and a beta of 1.02. The firm’s 50-day moving average is $1.64 and its 200 day moving average is $1.68. Organigram has a 1 year low of $1.20 and a 1 year high of $2.91.

Hedge Funds Weigh In On Organigram

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Toronto Dominion Bank grew its holdings in Organigram by 803.7% during the 3rd quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock valued at $30,000 after buying an additional 14,876 shares in the last quarter. Canton Hathaway LLC increased its stake in shares of Organigram by 115.8% during the second quarter. Canton Hathaway LLC now owns 41,000 shares of the company’s stock valued at $63,000 after buying an additional 22,000 shares during the period. Clear Harbor Asset Management LLC purchased a new position in shares of Organigram during the second quarter valued at $51,000. Baader Bank Aktiengesellschaft grew its stake in Organigram by 26.4% in the second quarter. Baader Bank Aktiengesellschaft now owns 252,852 shares of the company’s stock valued at $388,000 after purchasing an additional 52,852 shares during the last quarter. Finally, AdvisorShares Investments LLC grew its stake in Organigram by 11.8% in the second quarter. AdvisorShares Investments LLC now owns 1,000,126 shares of the company’s stock valued at $1,540,000 after purchasing an additional 105,468 shares during the last quarter. Institutional investors own 34.63% of the company’s stock.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.